Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Author contributions MM: Methodology, Writing original draft, Writing review & editing
Are we positioned for multi-receptor competition
And your doses are only as accurate as your reconstitution process
The drugs, which are currently in clinical trials but only for the treatment of noncirrhotic NASH, include the farnesoid X receptor agonist obeticholic acid (OCA), the thyroid hormone receptor THR agonist (Resmetirom), and Aramchol (bile acid and FA conjugate, cholic acidarachidic acid) (3032)
US$ 25.64
US$ 21.17
US$ 24.68
